- Revenue rose 8% YoY to $90.4M vs $84.0M in Q3 prior year
- GAAP net loss widened to $(13.2)M or $(0.48) per share; Non-GAAP net loss of $(2.4)M or $(0.09) per share
- GAAP gross margin compressed to 35.3% from 42.2% YoY; cash and investments stood at $652.4M
Why is $FLGT moving today? · SEC 8-K archive
$FLGT SEC Filing Alert & Real-Time AI Stock Impact Analysis
T0 SEO archive for $FLGT: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
FAQ: $FLGT filing catalyst
Why did $FLGT trigger an AI stock catalyst alert?
$FLGT triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -3.5/10). Headline: Fulgent Genetics Q3 Revenue Grows 8% to $90.4M, Net Loss Widens to $(0.48) GAAP EPS. Key points: - Revenue rose 8% YoY to $90.4M vs $84.0M in Q3 prior year - GAAP net loss widened to $(13.2)M or $(0.48) per share; Non-GAAP net loss of $(2.4)M or $(0.09) per share - GAAP gross margin compressed to 35.3% from 42.2% YoY; cash and investments stood at $652.4M
How did $FLGT stock react after the SEC filing?
After the SEC 8-K for $FLGT, observed market reaction: T0 price $18.66. Past moves do not guarantee future results.
Where can I get real-time $FLGT SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $FLGT via Telegram and the VIP Web Terminal from €10/month.